FDA inspection
Worldwide Clinical Trials Early Phase Servcies/Bioanalytical Sciences, Inc.: FDA inspection ending Aug 31, 2018
FDA inspection 1070668 · No Action Indicated (NAI) · Austin, TX
Key facts
| Inspection ID | 1070668 |
|---|---|
| Firm | Worldwide Clinical Trials Early Phase Servcies/Bioanalytical Sciences, Inc. |
| FEI number | 1000118998 |
| Address | 8609 Cross Park Dr |
| City | Austin |
| State | TX |
| ZIP | 78754 |
| Country | United States |
| Fiscal year | 2018 |
| Inspection end date | Aug 31, 2018 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data